Writing Committee Chair Larry B. Goldstein, MD, FAHA and with Vice Chair Peter P. Toth, MD, PhD, FAHA discuss a scientific statement from the American Heart Association that evaluates contemporary evidence supporting or refuting the idea that aggressive low-density lipoprotein cholesterol (LDL-C)-lowering or lipid-lowering might damage the brain causing cognitive impairment, dementia, or hemorrhagic stroke.
View supporting materials:
professional.heart.org/en/sci...